All News

A recent study investigated the associations of migraine with pain symptoms among outpatients with major depressive disorder during a 10-year period, finding that migraine treatment should be integrated into treatment for depression to improve patients’ pain symptoms and health-related quality of life.

When a patient experiences an adrenal crisis associated with Addison disease (primary adrenal failure), hydrocortisone and fluid resuscitation must be given immediately in order to prevent hypotensive shock and death. A recent clinical audit evaluated healthcare professionals’ management of adrenal crisis, and found that there is a clinical need to improve the acute management of this life-threatening condition.

A second biosimilar to Amgen’s Neupogen, which treats neutropenia, has been approved in the United States. The FDA approved Pfizer’s filgrastim-aafi, which will be sold under the brand name Nivestym. Zarxio (filgrastim-sndz) was the first filgrastim biosimilar approved by the FDA in 2015.

Data-broker companies are mining your credit card purchases, social media habits, online surveys, store loyalty programs, and other bits of information to create your profile and sell to companies interested in making inferences about your health status; 2 months after President Trump released a plan to lower drug prices, most Americans haven’t even heard about it; the United States Senate approved the president's latest pick to lead the troubled Department of Veterans Affairs (VA), confirming Robert Wilkie as the next secretary 86 to 9.

The Trump administration is proposing to pay doctors who take Medicare basically the same amount for office visits regardless of reason; the pending sale of Mission Health to HCA Healthcare reflects a national trend as hospitals consolidate at an accelerating pace and the cost of healthcare continues to rise; a closer look at 5 ideas in President Trump's plan to lower drug prices.

For vulnerable populations, their health and healthcare issues may be exacerbated by social factors. Here are just 5 vulnerable populations who experience greater risk factors, worse access to care, and increased morbidity and mortality compared with the general population.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text